One CRISPR treatment cut “bad” cholesterol in half for a full year
A single dose of an experimental CRISPR therapy cut LDL cholesterol and triglycerides by about half in patients with difficult-to-treat lipid disorders. The reductions were still present one year later, with the highest dose lowering LDL by 52.5%…
Read the full story at ScienceDaily Health ↗
ImpactMinor 28/100
Why it mattersRule-based estimate: no strong signals; trust 6/10.
RegionsGlobal
Published4 h ago (Sun, 27 Sep 2026 13:15:21 GMT)
RetrievedSun, 27 Sep 2026 16:00:47 GMT via rss
ClassifiedSun, 27 Sep 2026 16:00:58 GMT by heuristic